These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29894370)

  • 21. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women's Health Initiative in New York City.
    Setty P; Rekedal L; Warren MP
    Menopause; 2016 Jan; 23(1):7-10. PubMed ID: 26263282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urogenital atrophy: prevention and treatment.
    Willhite LA; O'Connell MB
    Pharmacotherapy; 2001 Apr; 21(4):464-80. PubMed ID: 11310520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
    Paton DM
    Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogens and the lower urinary tract.
    Robinson D; Cardozo L
    Neurourol Urodyn; 2011 Jun; 30(5):754-7. PubMed ID: 21661025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I stopped taking oral estrogen pills, and now vaginal dryness is a problem. My doctor suggested I use a vaginal cream containing estrogen. Is estrogen given this way absorbed by the body?
    Mayo Clin Health Lett; 2003 Aug; 21(8):8. PubMed ID: 12971311
    [No Abstract]   [Full Text] [Related]  

  • 29. Why the product labeling for low-dose vaginal estrogen should be changed.
    Manson JE; Goldstein SR; Kagan R; Kaunitz AM; Liu JH; Pinkerton JV; Rebar RW; Schnatz PF; Shifren JL; Stuenkel CA; Gass ML; Utian WH;
    Menopause; 2014 Sep; 21(9):911-6. PubMed ID: 25140698
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women.
    Tucker KM; Godha K; Mirkin S; Archer DF
    Menopause; 2018 Jul; 25(7):762-766. PubMed ID: 29509598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
    Del Pup L
    Gynecol Endocrinol; 2012 Sep; 28(9):740-5. PubMed ID: 22409649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
    Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
    Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of vaginal atrophy: a real mess. Results from the AGATA study.
    Palma F; Xholli A; Cagnacci A;
    Gynecol Endocrinol; 2017 Sep; 33(9):702-707. PubMed ID: 28391746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and its effect on vaginal atrophy in post-menopausal women.
    Kelley C
    Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.
    Rees M; Pérez-López FR; Ceasu I; Depypere H; Erel T; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; van der Schouw Y; Tremollieres F;
    Maturitas; 2012 Oct; 73(2):171-4. PubMed ID: 22818886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal Estrogen-What a Urologist Should Know.
    Escobar C; Rosenblum N
    Urology; 2021 May; 151():37-43. PubMed ID: 32504683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic estradiol levels with low-dose vaginal estrogens.
    Santen RJ; Mirkin S; Bernick B; Constantine GD
    Menopause; 2020 Mar; 27(3):361-370. PubMed ID: 31794498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mayo Clinic office visit. Vaginal dryness. An interview with Rosalina Abboud,M.D.
    Abboud R
    Mayo Clin Womens Healthsource; 2009 Jun; 13(6):6. PubMed ID: 19415047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.